Once the tumor barrier is destroyed, a large number of PSA randomly enters the lymphatic system, resulting in increased concentrations of PSA and f PSA in blood.23 In this study, the serum PSA and f PSA levels in the two groups after treatment were significantly lower than those before treatment, but the intensity-modulated radiotherapy group decreased more significantly than the conventional group. This evidence concerns the gene KLK3 and neoplasm.